June 13, 2018
Ionis Pharmaceuticals has once again retained The Chase Group to assist them in finding high caliber talent to join their growing team. Due to exciting organizational growth, Ionis is looking for a new Director, Investor Relations with a track record of exceptional investor relations strategy and execution, as well as strong relationships with investors and analysts. Ionis depends on The Chase Group for their expertise and knowledge of this critical functional area and our ability to find the right people to meet their business needs. Ionis is a financially strong company with a robust pipeline and this unique opportunity will have a meaningful impact as the company strives to discover and develop antisense drugs to treat a variety of health conditions, with an emphasis on cardiovascular, metabolic, severe and rare diseases, including neurological diseases and cancer. For more information, contact Bonnie Stofer at bonnie@chasegroup.com
